Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatment of serious diseases with significant unmet medical needs in the orphan drug segment

Upcoming event

February 22, 2024

Year-end Report Q4 2023

Latest presentation

December 19, 2023

Egetis Investor Day 2023

Latest Report

November 8, 2023

Q3 Report 2023

Calendar and upcoming reports

February 22, 2024

Year-end Report Q4 2023

March 5-6, 2024

Carnegie Nordic Healthcare Seminar

May 3, 2024

Interim Report Q1 2024

May 6, 2024

Annual General Meeting

Joshua’s Story

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com